Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice
Benneth Ben‐Azu, Christian I. Uruaka, Abayomi M. Ajayi, et al.
Neurochemical Research (2022) Vol. 48, Iss. 3, pp. 816-829
Closed Access | Times Cited: 22

Showing 22 citing articles:

Diosgenin alleviates alcohol-mediated escalation of social defeat stress and the neurobiological sequalae
Benneth Ben‐Azu, Emuesiri Goodies Moke, LE Chris-Ozoko, et al.
Psychopharmacology (2024) Vol. 241, Iss. 4, pp. 785-803
Closed Access | Times Cited: 17
Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission
Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, et al.
IBRO Neuroscience Reports (2024) Vol. 16, pp. 86-97
Open Access | Times Cited: 13
The protective role of ginsenoside Rg3 in heart diseases and mental disorders
Lili Shi, Jinlan Luo, Xiupan Wei, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Containment of neuroimmune challenge by diosgenin confers amelioration of neurochemical and neurotrophic dysfunctions in ketamine-induced schizophrenia in mice
Benneth Ben‐Azu, Olusegun G. Adebayo, Aliance Romain Fokoua, et al.
Brain Disorders (2024) Vol. 13, pp. 100122-100122
Open Access | Times Cited: 7
Effective Action of Silymarin against Ketamine-induced Schizophrenia in Male Mice: Insight into the Biochemical and Molecular Mechanisms of Action
Benneth Ben‐Azu, Aliance Romain Fokoua, Olajide S. Annafi, et al.
Journal of Psychiatric Research (2024) Vol. 179, pp. 141-155
Closed Access | Times Cited: 6
Emerging epigenetic dynamics in gut-microglia brain axis: experimental and clinical implications for accelerated brain aging in schizophrenia
Benneth Ben‐Azu, Elisabetta C. del Re, Jared VanderZwaag, et al.
Frontiers in Cellular Neuroscience (2023) Vol. 17
Open Access | Times Cited: 15
Alcohol-exacerbates post-traumatic stress psychiatric behavior and its neuropathological sequalae in experimental mice: preventive effects of morin
Benneth Ben‐Azu, Pere-Ebi Yabrade Toloyai, Adaeze Adebesin, et al.
Alcohol (2024)
Closed Access | Times Cited: 5
Effects of combined postweaning social isolation and ketamine administration on schizophrenia-like behaviour in male Sprague Dawley rats
Khanyiso Bright Shangase, Mluleki Luvuno, Musa V. Mabandla
Behavioural Brain Research (2024) Vol. 476, pp. 115214-115214
Open Access | Times Cited: 5
Mechanisms of vagus nerve stimulation for the treatment of neurodevelopmental disorders: a focus on microglia and neuroinflammation
Makenna Gargus, Benneth Ben‐Azu, Antonia Landwehr, et al.
Frontiers in Neuroscience (2025) Vol. 18
Open Access
Multiscale Synergy Networks Offer Insights into Disease and Comorbidity Mechanisms
Yongpei Wang, Zeyu Zhu, Lingli Deng, et al.
Analytical Chemistry (2025)
Closed Access
Impact of Relapse in BDNF Receptors Expression in Patients With a First Episode of Schizophrenia
Miquel Bioque, Vicent Llorca-Bofí, Karina S. MacDowell, et al.
Schizophrenia Bulletin (2025)
Closed Access
Brain-derived neurotrophic factor (BDNF) changes in rodent models of schizophrenia induced by ketamine: a systematic review
Atefeh Motamedi-Manesh, Mahdieh Farzin Asanjan, Hamed Fallah, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2025)
Closed Access
Ketamine-Induced Behavioral Perturbations, Redox Imbalances, and Neurotransmitter Deficits in Mice: The Preventive and Reversal Neuromodulatory Potential of Diosmin as an Antipsychotic
Aya-Ebi Okubo Eneni, Benneth Ben‐Azu, Abayomi M. Ajayi, et al.
Brain Disorders (2025), pp. 100210-100210
Open Access
Potential Roles of Natural Antioxidants in Modulating Neurodegenerative Disease Pathways
Mega Obukohwo Oyovwi, Ejime A. Chijiokwu, Benneth Ben‐Azu, et al.
Molecular Neurobiology (2025)
Closed Access
Ginkgo biloba supplement modulates mTOR/ERK1/2 activities to mediate cardio-protection in cyclosporin-A-induced cardiotoxicity in Wistar rats
Jerome Ndudi Asiwe, Benneth Ben‐Azu, Godwin D. Yovwin, et al.
Deleted Journal (2024) Vol. 5, Iss. 1, pp. 200134-200134
Open Access | Times Cited: 2
Effects of association between resveratrol and ketamine on behavioral and biochemical analysis in mice
Patrícia Zorzi Juliani, Talita Rodrigues, Getúlio Nicola Bressan, et al.
Journal of Neural Transmission (2024) Vol. 131, Iss. 8, pp. 971-986
Closed Access | Times Cited: 2
D-ribose-L-cysteine exhibits restorative neurobehavioral functions through modulation of neurochemical activities and inhibition oxido-inflammatory perturbations in rats exposed to polychlorinated biphenyl
Mega Obukohwo Oyovwi, Benneth Ben‐Azu, Faith Y. Falajiki, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 397, Iss. 2, pp. 931-945
Closed Access | Times Cited: 6
Influence of the dose of ketamine used on schizophrenia-like symptoms in mice: A correlation study with TH, GAD67, and PPAR-γ
Talita Rodrigues, Getúlio Nicola Bressan, Bárbara Nunes Krum, et al.
Pharmacology Biochemistry and Behavior (2023) Vol. 233, pp. 173658-173658
Open Access | Times Cited: 4
Co-enzyme-Q10 and taurine abate isoprenaline-mediated hepatorenal dysregulations and oxidative stress in rats
Emuesiri Goodies Moke, Jerome Ndudi Asiwe, Benneth Ben‐Azu, et al.
Clinical Nutrition Open Science (2024) Vol. 57, pp. 10-25
Open Access | Times Cited: 1
Is the antidepressant effect of ketamine separate from its psychotomimetic effect? A review of rodent models
María Camila Acero-Castillo, M B M Correia, Fábio V. Caixeta, et al.
Neuropharmacology (2024) Vol. 258, pp. 110088-110088
Closed Access
The immune regulatory mechanism of ketamine-induced psychiatric disorders: A new perspective on drug-induced psychiatric symptoms
Peipei Wang, Junmei Hu, Congliang Chen, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111194-111194
Closed Access
Acute ketamine induces neuronal hyperexcitability and deficits in prepulse inhibition by upregulating IL-6
Yayan Luo, Yu Yang, Hongbo He, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2023) Vol. 130, pp. 110913-110913
Closed Access | Times Cited: 1
Page 1

Scroll to top